Literature DB >> 78051

Immunoproliferation and cancer: a common macrophage-derived promoter substance.

S E Salmon, A W Hamburger.   

Abstract

It is suggested that a common proliferative factor is required for the growth of clones of both antigen-triggered B lymphocytes and carcinogen-triggered epithelial cells, and that the common growth-promoting substance is secreted by macrophages which have originally differentiated in support of the immune response. This macrophage-derived factor seems to be antigenically distinct from granulocyte colony-stimulating factor. Identification of the macrophage-derived clonal proliferative factor could provide new understanding of the proliferation of clones of immunocytes and neoplastic cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 78051     DOI: 10.1016/s0140-6736(78)91270-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  15 in total

1.  Peritoneal macrophages from adjuvant arthritic rats enhance tumour cell growth in vitro.

Authors:  L Binderup; E Bramm; E Arrigoni-Martelli
Journal:  Experientia       Date:  1979-09-15

2.  Immunoregulating activity of tumor-associated macrophages.

Authors:  G J Dougherty; W H McBride
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Enhancement of rat ACT-1 tumor clonogenicity by xenogeneic mouse macrophages.

Authors:  K W Beagley; L S Horne; R F Noronha; C M Goodall; C M Moore
Journal:  In Vitro       Date:  1984-08

4.  A simple procedure for removal of intra- and extra-tumoral macrophages from primary tumor cultures.

Authors:  Y Yamamura; B C Fischer; K R Madyastha; J W Proctor
Journal:  Experientia       Date:  1981-03-15

5.  Changes in immune reactivity during growth of an adenovirus 12-induced transplantable tumour in CBA mice.

Authors:  V Britten; J C Underwood
Journal:  Experientia       Date:  1981-05-15

6.  Vindesine. A clinical trial with special reference to neurological side effects.

Authors:  R Obrist; U Paravicini; D Hartmann; G A Nagel; J P Obrecht
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

Review 7.  The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally?

Authors:  Teizo Yoshimura
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

8.  The pattern of the mononuclear infiltrate as a prognostic parameter in flat superficial spreading melanomas.

Authors:  E B Bröcker; G Kolde; D Steinhausen; A Peters; E Macher
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

Review 9.  Prediction of response to drug therapy of cancer. A review of in vitro assays.

Authors:  W T Bellamy
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

Review 10.  Macrophages and neoplasms: new insights and their implication in tumor immunobiology.

Authors:  R Evans
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.